Concepedia

Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy

Vivek Thumbigere‐Math, Bryan S. Michalowicz, Pamela Hughes, David L. Basi, Michaela L. Tsai, Karen K. Swenson, Laura Rockwell, Rajaram Gopalakrishnan

Journal of Oral and Maxillofacial Surgery · 2015 · 33 citations · 37 references

DOIFull text

Open access

Concepts

References

37

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Salvatore L. Ruggiero, Thomas B. Dodson, John E Fantasia et al. · Journal of Oral and Maxillofacial Surgery · 2014 · 2.9K citations

, , +3

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

, , +12

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment

Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations

, , +16

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update

Salvatore L. Ruggiero, Thomas B. Dodson, Leon A. Assael et al. · Journal of Oral and Maxillofacial Surgery · 2009 · 1.3K citations

, , +8

Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment

Joseph E. Cillo, Juan J. Ulloa · Journal of Oral and Maxillofacial Surgery · 2007 · 718 citations

, , +15